Corcept Therapeutics (CORT) Capital Expenditures Growth (1y) (2013 - 2026)
Corcept Therapeutics (CORT) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Corcept Therapeutics |
8.35 Bn |
8.01 Bn |
162.02 Mn |
93.27% |
| Date | Value |
|---|
| Mar 31, 2026 |
93.27% |
| Dec 31, 2025 |
-58.68% |
| Jun 30, 2025 |
-86.30% |
| Sep 30, 2024 |
4,318.92% |
| Jun 30, 2024 |
307.84% |
| Sep 30, 2023 |
-89.46% |
| Jun 30, 2023 |
436.84% |
| Dec 31, 2022 |
-52.31% |
| Sep 30, 2022 |
120.75% |
| Jun 30, 2022 |
-84.03% |
| Mar 31, 2022 |
-90.48% |
| Dec 31, 2021 |
-84.92% |
| Sep 30, 2021 |
-77.86% |
| Jun 30, 2021 |
153.19% |
| Mar 31, 2021 |
200.00% |
| Dec 31, 2020 |
219.26% |
| Sep 30, 2020 |
151.05% |
| Jun 30, 2020 |
-88.54% |
| Mar 31, 2020 |
-83.66% |
| Dec 31, 2019 |
19.47% |
